Pembrolizumab for Previously Treated, PD-L1–expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival

Vamsidhar Velcheti, Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Pembrolizumab for Previously Treated, PD-L1–expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival'. Together they form a unique fingerprint.

Medicine & Life Sciences